دورية أكاديمية
أعرض في EDS

Inter-epidemic Rift Valley fever virus infection incidence and risks for zoonotic spillover in northern Tanzania.

التفاصيل البيبلوغرافية
العنوان: Inter-epidemic Rift Valley fever virus infection incidence and risks for zoonotic spillover in northern Tanzania.
المؤلفون: de Glanville WA; School of Biodiversity, One Health, and Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.; University of Global Health Equity, Kigali, Rwanda., Nyarobi JM; School of Biodiversity, One Health, and Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.; Nelson Mandela African Institution of Science and Technology, Arusha, Tanzania., Kibona T; Nelson Mandela African Institution of Science and Technology, Arusha, Tanzania., Halliday JEB; School of Biodiversity, One Health, and Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom., Thomas KM; Centre for International Health, University of Otago, Dunedin, New Zealand.; Kilimanjaro Clinical Research Institute, Moshi, United Republic of Tanzania., Allan KJ; School of Biodiversity, One Health, and Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom., Johnson PCD; School of Biodiversity, One Health, and Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom., Davis A; School of Social and Political Sciences, University of Glasgow, Glasgow, United Kingdom., Lankester F; Paul G. Allen School for Global Health, Washington State University, Pullman, Washington, United States of America.; Global Animal Health Tanzania, Arusha, Tanzania., Claxton JR; School of Biodiversity, One Health, and Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom., Rostal MK; School of Biodiversity, One Health, and Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.; EcoHealth Alliance, New York, New York, United States of America., Carter RW; School of Biodiversity, One Health, and Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom., de Jong RMF; School of Biodiversity, One Health, and Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom., Rubach MP; Division of Infectious Diseases and International Health, Duke University Medical Center, Durham, North Carolina, United States of America.; Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America.; Programme in Emerging Infectious Diseases, Duke-National University of Singapore, Singapore., Crump JA; Centre for International Health, University of Otago, Dunedin, New Zealand.; Division of Infectious Diseases and International Health, Duke University Medical Center, Durham, North Carolina, United States of America.; Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America.; Kilimanjaro Christian Medical University College, Tumaini University, Moshi, Tanzania., Mmbaga BT; Kilimanjaro Clinical Research Institute, Moshi, United Republic of Tanzania.; Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America.; Kilimanjaro Christian Medical University College, Tumaini University, Moshi, Tanzania., Nyasebwa OM; Ministry of Livestock and Fisheries, Dodoma, United Republic of Tanzania., Swai ES; Ministry of Livestock and Fisheries, Dodoma, United Republic of Tanzania., Willett B; MRC University of Glasgow Centre for Virus Research, Glasgow, United Kingdom., Cleaveland S; School of Biodiversity, One Health, and Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
المصدر: PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2022 Oct 28; Vol. 16 (10), pp. e0010871. Date of Electronic Publication: 2022 Oct 28 (Print Publication: 2022).
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101291488 Publication Model: eCollection Cited Medium: Internet ISSN: 1935-2735 (Electronic) Linking ISSN: 19352727 NLM ISO Abbreviation: PLoS Negl Trop Dis Subsets: MEDLINE
أسماء مطبوعة: Original Publication: San Francisco, CA : Public Library of Science
مواضيع طبية MeSH: Rift Valley fever virus* , Rift Valley Fever*, Sheep ; Cattle ; Animals ; Humans ; Seroepidemiologic Studies ; Cross-Sectional Studies ; Incidence ; Tanzania/epidemiology ; Antibodies, Viral ; Zoonoses/epidemiology ; Goats ; Livestock
مستخلص: Rift Valley fever virus (RVFV) is a mosquito-borne pathogen that has caused epidemics involving people and animals across Africa and the Arabian Peninsula. A number of studies have found evidence for the circulation of RVFV among livestock between these epidemics but the population-level incidence of infection during this inter-epidemic period (IEP) is rarely reported. General force of infection (FOI) models were applied to age-adjusted cross-sectional serological data to reconstruct the annual FOI and population-level incidence of RVFV infection among cattle, goats, and sheep in northern Tanzania from 2009 through 2015, a period without reported Rift Valley fever (RVF) cases in people or animals. To evaluate the potential for zoonotic RVFV spillover during this period, the relationship between village-level livestock RVFV FOI and human RVFV seropositivity was quantified using multi-level logistic regression. The predicted average annual incidence was 72 (95% Credible Interval [CrI] 63, 81) RVFV infections per 10,000 animals and 96 (95% CrI 81, 113), 79 (95% CrI 62, 98), and 39 (95% CrI 28, 52) per 10,000 cattle, sheep, and goats, respectively. There was variation in transmission intensity between study villages, with the highest estimated village-level FOI 2.49% (95% CrI 1.89, 3.23) and the lowest 0.12% (95% CrI 0.02, 0.43). The human RVFV seroprevalence was 8.2% (95% Confidence Interval 6.2, 10.9). Human seropositivity was strongly associated with the village-level FOI in livestock, with the odds of seropositivity in an individual person increasing by around 1.2 times (95% CrI 1.1, 1.3) for each additional annual RVFV seroconversion per 1,000 animals. A history of raw milk consumption was also positively associated with human seropositivity. RVFV has circulated at apparently low levels among livestock in northern Tanzania in the period since the last reported epidemic. Although our data do not allow us to confirm human RVFV infections during the IEP, a strong association between human seropositivity and the FOI in cattle, goats, and sheep supports the hypothesis that RVFV circulation among livestock during the IEP poses a risk for undetected zoonotic spillover in northern Tanzania. We provide further evidence for the likely role of raw milk consumption in RVFV transmission from animals to people.
Competing Interests: The authors have declared that no competing interests exist.
(Copyright: © 2022 de Glanville et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
References: Onderstepoort J Vet Res. 2014 Apr 23;81(2):E1-5. (PMID: 25005550)
Am J Trop Med Hyg. 2007 May;76(5):795-800. (PMID: 17488893)
Proc Natl Acad Sci U S A. 2018 Jul 31;115(31):E7448-E7456. (PMID: 30021855)
Vector Borne Zoonotic Dis. 2017 Feb;17(2):141-146. (PMID: 27929928)
Transbound Emerg Dis. 2015 Feb;62(1):13-23. (PMID: 23551913)
PLoS Negl Trop Dis. 2013 Aug 08;7(8):e2356. (PMID: 23951376)
Trans R Soc Trop Med Hyg. 2022 Nov 1;116(11):1082-1090. (PMID: 36040309)
Virology. 2016 Feb;489:128-40. (PMID: 26748334)
PLoS Negl Trop Dis. 2019 Mar 20;13(3):e0007258. (PMID: 30893298)
Front Vet Sci. 2019 Aug 14;6:258. (PMID: 31475162)
Infect Ecol Epidemiol. 2015 Nov 18;5:30025. (PMID: 26584830)
PLoS Negl Trop Dis. 2016 Dec 21;10(12):e0005167. (PMID: 28002417)
Trop Med Int Health. 2014 Dec;19(12):1420-9. (PMID: 25252137)
Front Vet Sci. 2022 Jun 14;9:897481. (PMID: 35774979)
J Int AIDS Soc. 2012 Mar 14;15(1):14. (PMID: 22417328)
Int J Epidemiol. 1997 Feb;26(1):224-7. (PMID: 9126524)
PLoS Negl Trop Dis. 2019 May 3;13(5):e0007296. (PMID: 31050673)
Vaccine. 2014 Apr 25;32(20):2337-44. (PMID: 24631070)
J Anim Breed Genet. 2017 Dec;134(6):531-544. (PMID: 28345262)
PLoS Negl Trop Dis. 2021 Aug 24;15(8):e0009630. (PMID: 34428205)
J Epidemiol Community Health. 2005 Jun;59(6):443-9. (PMID: 15911637)
Parasit Vectors. 2016 Mar 31;9:184. (PMID: 27036889)
Epidemiol Infect. 2018 Dec 05;147:e67. (PMID: 30516123)
Annu Rev Entomol. 2016;61:395-415. (PMID: 26982443)
Ecology. 2006 Sep;87(9):2356-65. (PMID: 16995636)
J Infect Dis. 1984 Mar;149(3):311-9. (PMID: 6371153)
Am J Trop Med Hyg. 2019 Aug;101(2):459-466. (PMID: 31219026)
Emerg Infect Dis. 2008 Aug;14(8):1240-6. (PMID: 18680647)
Zoonoses Public Health. 2020 Aug;67(5):496-505. (PMID: 32374085)
Pathogens. 2021 Jun 05;10(6):. (PMID: 34198898)
Am J Trop Med Hyg. 2011 Apr;84(4):641-6. (PMID: 21460024)
Sci Rep. 2022 Jul 8;12(1):11669. (PMID: 35803982)
J Am Mosq Control Assoc. 1985 Mar;1(1):93-5. (PMID: 2906661)
Epidemiol Infect. 2010 Jun;138(6):802-12. (PMID: 19765352)
PLoS Negl Trop Dis. 2020 Jul 20;14(7):e0008061. (PMID: 32687540)
Emerg Infect Dis. 2005 Nov;11(11):1693-700. (PMID: 16318720)
iScience. 2020 Oct 14;23(11):101669. (PMID: 33134899)
PLoS Negl Trop Dis. 2015 Feb 27;9(2):e0003536. (PMID: 25723502)
Antiviral Res. 2020 Feb;174:104692. (PMID: 31870761)
Anim Genet. 2012 Feb;43(1):63-71. (PMID: 22221026)
Res Vet Sci. 1967 Oct;8(4):406-14. (PMID: 6070723)
PLoS Negl Trop Dis. 2018 Nov 12;12(11):e0006931. (PMID: 30418975)
PLoS One. 2020 Dec 30;15(12):e0229478. (PMID: 33378382)
PLoS Negl Trop Dis. 2011 Dec;5(12):e1423. (PMID: 22206026)
Glob Health Action. 2021 Jan 1;14(1):1957554. (PMID: 34415237)
Front Vet Sci. 2019 Sep 26;6:327. (PMID: 31681800)
PLoS One. 2014 Feb 25;9(2):e88897. (PMID: 24586433)
Environ Health. 2013 Oct 04;12(1):85. (PMID: 24093917)
PLoS Negl Trop Dis. 2012;6(3):e1557. (PMID: 22479657)
Tanzan J Health Res. 2011 Dec;13(5 Suppl 1):305-18. (PMID: 26591986)
PLoS Negl Trop Dis. 2018 Jul 23;12(7):e0006627. (PMID: 30036382)
J Virol Methods. 2013 Jan;187(1):177-81. (PMID: 23022325)
Vet Rec. 2005 Nov 12;157(20):619-23. (PMID: 16284330)
BMC Infect Dis. 2018 Jun 14;18(1):276. (PMID: 29898686)
PLoS Negl Trop Dis. 2021 Jan 25;15(1):e0008100. (PMID: 33493173)
Sci Rep. 2017 Jan 04;7:39870. (PMID: 28051125)
Viruses. 2020 Feb 07;12(2):. (PMID: 32046120)
Transbound Emerg Dis. 2018 Feb;65(1):e55-e62. (PMID: 28710814)
معلومات مُعتمدة: BB/L018926/1 United Kingdom BB_ Biotechnology and Biological Sciences Research Council; BB/N503563/1 United Kingdom BB_ Biotechnology and Biological Sciences Research Council; BB/J010367/1 United Kingdom BB_ Biotechnology and Biological Sciences Research Council; BB/L017679/1 United Kingdom BB_ Biotechnology and Biological Sciences Research Council; BB/J010367 United Kingdom BB_ Biotechnology and Biological Sciences Research Council; MC_UU_12014/10 United Kingdom MRC_ Medical Research Council
المشرفين على المادة: 0 (Antibodies, Viral)
تواريخ الأحداث: Date Created: 20221028 Date Completed: 20221118 Latest Revision: 20230802
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC9665400
DOI: 10.1371/journal.pntd.0010871
PMID: 36306281
قاعدة البيانات: MEDLINE
الوصف
تدمد:1935-2735
DOI:10.1371/journal.pntd.0010871